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Streptolysin S, a hemolytic toxin produced  by beta hemolytic streptococci, 
has been reported to elicit the transformation  1 of human peripheral blood lym- 
phocytes cultured in vitro into large, blast-like cells,  and to stimulate mitosis 
(1). This effect appeared to differ from the transformation elicited by antigens 
in the lymphocytes of specifically sensitized subjects because the per cent of 
transformation was higher,  and because transformation was  obtained in the 
lymphocytes from all the normal subjects tested. Moreover, the preparation 
used, streptolysin S, had been reported not to behave as an antigen in naturally 
occurring streptococcal infections in man or in immunization experiments in 
animals (2, 3). It was concluded that the action of streptolysin S on cultures of 
human peripheral blood lymphocytes is nonspecific in the immunologic sense 
and qualitatively similar to that of phytohemagglutinin (PHA)  (4),  though 
quantitatively less marked. Preparations of the other hemolytic streptococcal 
toxin, streptolysin O, behaved like any other specific antigen (1). Streptolysin S 
is of interest because it is one of the most potent hemolytic agents known (5), 
and because it has been implicated in the pathogenesis of rheumatic fever (for 
reviews see references 6-8). 
The great majority of strains of Group A beta hemolytic streptococci produce 
streptolysin S, but a few do not (9). One of these strains unable to produce strep- 
tolysin S, the C203U strain originally described as derived by mutation from a 
streptolysin S-producing strain (C203S),  has recently been reported to produce a 
potent lymphocy[e-transforming factor under conditions customarily adopted 
for the production of streptolysin S  (10).  This finding suggested the general 
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Presented in part  at the  7th Congress of the International Academy of Pathology, 
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1  Other terms used in the literature are "activation," "stimulation," and "blast transforma- 
tion." 
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hypothesis [I] that the hemolytic and the transforming activities of streptolysin 
S  preparations may be independent of each other,  and the specific hypotheses 
that they may be attributes of  two different molecules [Ia], or of  two different 
active sites of the same molecule [I b]. 
We report here a  series of experiments bearing on these hypotheses.  Experi- 
ments based on the characteristic sensitivity of the hemolytic activity of strep- 
tolysin S  to heat  (11), to chymotrypsin (12), and to certain inhibitors (13,  14) 
supported  the  general hypothesis  [1].  Support  for  the first  specific hypothesis 
[Ia] was derived from fractionation experiments. 
Materials and Methods 
Bacterial Strains.--Strain  C203S of Group A streptococcus,  used previously for streptolysin 
S production (12), and strain 010962 of Diplococcus pneumoniae, type I, were obtained from 
Dr.  Alan W.  Bernheimer. Strains of Streptococcus viridans and of Staphylococcus anreus 
(nonhemolytic) were isolated in this laboratory from healthy carriers. 
Streptolysin  S  Preparat3ons.--These preparations were obtained according to  a  method 
derived from that of Bernheimer (12) with minor modifications,  including that of Ginsburg 
and Bentwich (15).  Briefly,  streptococci of  the C203S  strain were  grown in Todd-Hewitt 
broth (Dffeo Laboratories, Detroit, Mich.) and the overnight growth was inoculated 1 : 10 in 
5 liter batches of the same broth. The streptococci were collected  by centrifugation in the 
cold as soon as they approached the stationary phase of growth, usually 6-7 hr after inocula- 
tion. They were then washed twice and incubated in 70 ml of a medium (hereafter referred  to 
as  "suspension medium") containing phosphate, maltose  (Fisher  Scientific  Co.,  Fairlawn, 
N.J.), L-cysteine base (Mann Research Laboratories, New York, N.Y.), and the residuum of 
pancreatic RNAse digestion of yeast RNA ("RNA core"--Worthington Biochemical Corp., 
Freehold, N.J.). Incubation  was carried out for 2 hr at 37°C, at the end of which the strepto- 
cocci were centrifuged out and the supernatant was passed through Millipore filters of 0.22 # 
pore size. The preparations obtained were then dialyzed and lyophilized, or preserved in the 
frozen state, or subjected to fractionation experiments as described  below.  Various lots of 
streptolysin S preparation (also referred  to in the literature as "C203S  product" [10, 12] or 
RNA-hemolysin [16, 17]) had hemolytic activities ranging from 9,600 to 27,000 50% hemolytic 
units (HUs0)/ml before dialysis, and from 15,000 to 27,000 I-IU60/mg after dialysis and lyo- 
philization. Most of the experiments reported here were done with a dialyzed and lyophillzed 
lot containing  20,000 I-IUs0/mg. The term "streptolysin S preparation" is preferred to that of 
"streptolysin S" which may be misleadingly construed to imply purity of such preparations. 
Determinaffon of the Hemolytic Activity of Streptolysin S Preparatlons.--This  procedure was 
carried out as described by Berrgaeimer (12) with a minor modification (the 0.35% human red 
cell suspension was standardized on the basis of the optical density at 541 m/z after lysis, and 
the determination of per cent hemolysis was also determined by the optical density at 541 m/z 
in a Beckman DU spectrophotometer)~  These determinations were clone on the same days in 
which lymphocyte culture experiments or chromatographic fractionations of streptolysin S 
preparations were done. Since the sensitivity of washed erythrocytes to streptolysin S slowly 
increases even when the suspension is stored at 3-5°C (9), the red cell suspension was freshly 
prepared each day. The hemolytic activity was expressed in HU60. The latter was defined as 
that amount of streptolysin S which lyses 50% of 1 ml of a 0.35% red cell suspension (12). 
Dilutions were made in pit 7 phosphate-buffered saline (1/15 z~ sodium phosphate, 1/12.9 x~ 
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In critical experiments in which it appeared important to rule out the presence of minute 
amounts of streptolysln S hemolytic activity, lower than can be detected with the above stand- 
ard test, a sensitized test was adopted, as suggested by Ginsburg et al. (18), using as diluent 
a hypotonic phosphate-buffered saline and substituting a 0.1% suspension of red cells for the 
standard 0.35% suspension. 
Determination of the Transforming Activity  of Streptolysin S  Preparatlons.--Two  different 
methods were used. 
Thefirst method, which was used in all the experiments, was derived from that of Bach and 
Hirschhorn (19). For each experiment, 400 ml of blood were collected in a plastic bag contain- 
ing 2250 units of heparin sodium USP in 30 mi of sterile, pyrogen-free 0.9% sodium chloride 
solution buffered with sodium phosphate USP (Fenwali Laboratories, Morton Grove, Ill.), to 
which were added 40 mi of 6% dextran 70 (approximate molecular weight 70,000)  in sterile, 
pyrogen-free, 0.9% sodium chloride solution (Travenol Laboratories, Morton Grove, Ill.). The 
blood was left to sediment in the plastic bag kept in an upright position at 37°C for approxi- 
mately la/~ hr. The supernatant leukocyte-rich plasma was transferred into a flat-sided bottle 
which was kept lying on one of its wide sides for 1 hr at 37°C to expose the blood to a larger 
surface of glass, to which the neutrophils adhere, and thus to reduce the percentage of neutro- 
phils. The plasma was then centrifuged at 130 relative centrifugal force (RCF) for 10 min and 
the sedimented cells were washed twice in 400 ml of Eagle's minimum essential medium modi- 
fied for spinner culters  (MEM-S,  Grand Island Biological Co.,  Grand Island, N. Y.).  The 
cells were  resuspended in a medium containing 77% MEM-S, 20% fetal calf serum, 1% 200 
ham solution of ~gluta-amine, and 2% of a  solution containing 5000 units of penicillin and 
5000 units of streptomycin/ml (all obtained from Grand Island Biological Co.,  Grand  Island, 
N. Y.; this medium will be referred to as "enriched MEM-S"). The concentration of cells was 
adjusted to 106/ml. 4 ml aliquots of the cell suspension were transferred into flat-bottom, screw- 
cap, 30 ml bottles. Streptolysin S preparations were added in 0.1 ml amounts per bottle with 
exception of  the chromatographic fractions, which were added in 0.2 ml amounts. In each 
experiment, positive controls were provided by duplicate or triplicate bottles to which 0.1 ml 
aliquots  of  a  PHA  preparation  (Burroughs  Wellcome,  Wellcome  Research  Laboratories, 
Beckenham, England) were added, and negative controls were provided by triplicate or quad- 
ruplicate bottles to which neither PHA nor streptolysin S preparations were added. The caps 
were tightly closed, the contents mixed, and the bottles incubated for 5 days, with the excep- 
tion of the ones containing PHA, which were incubated for 3 days. At the end of the incuba- 
tion period, the cells were harvested by centrifugation for 10 rain at 130 RCF and smeared 
on microscope slides,  one slide for each bottle. The slides were  air-dried  and stained with 
Wright's stain. They were given random coded numbers and then read "blindly," i.e., without 
knowing whether PHA or streptolysin S preparation or neither had been added to the corre- 
sponding cultures, nor which were the sets of replicates. The percentage of transformation 
was determined by examining 1000 cells per slide. Cells in mitosis were counted as transformed 
cells.  The per cent of transformation was recorded as such, i.e.,  without subtracting the per 
cent transformation observed in the control cultures with no additives. In such control cul- 
tures the transformation averaged 1.1%. 
In a small series of experiments in which a single dose of heated and of unheated streptolysin 
S preparation were tested, only 30 ml of blood were used for each experiment, and the first steps 
of the above procedure were consequently modified as follows.  The blood was collected in a 
plastic syringe and poured into glass tubes containing 200 units of heparin and 3 ml of 6% 
dextran in saline. It was then left to sediment in the tubes, inclined at a 45  ° angle for approxi- 
mately 1 hr at 37°C. The rest of the procedure was as described above. 
The second method, which was used only in the experiments on chromatographic fractions of 
streptolysin S preparations, was derived from those of Dutton and Eady (20)  and of Caron 608  TRANSFORMING  ACTIVITY  OF  STREPTOLYSIN  S PREPARATIONS 
et ai. (21) as modified by Valentine and Lawrence.  ~ For each experiment, 400 ml of blood were 
collected and left to sediment as described above. However, to reduce the percentage of neutro- 
phils, the supernatant leukocyte-rich plasma was poured into stoppered 100 ml glass syringes 
loosely packed with glass wool (previously sterilized by dry heat at 160°C for 4 hr), and incu- 
bated for ~  hr at 37°C. The stopper was then removed and the plasma collected. The syringes 
were then washed with MEM-S in an amount double that of the plasma recovered. The wash- 
ings were added to the plasma, and the mixture was centrifuged at 260 RCF for 10 min. The 
sedimented cells were resuspended in 10 ml of enriched MEM-S. The concentration of the cells 
was adjusted to 106 cells/ml and the cell suspension was transferred in 4 ml aliquots into screw- 
cap glass tubes,  16  X  125  mm. The solutions to be assayed for transforming activity were 
added in 0.2 ml amounts. The tubes were flushed with 5% CO~ in air. The caps were screwed 
tightly and the tubes incubated at 37°C for 3 days (for tubes containing PHA, i.e., positive 
controls) or for 5 days (for tubes containing chromatographic fractions of streptolysin S prep- 
arations, and for tubes containing no additives, i.e., negative controls). 
24 hr before harvesting the cells, 0.1 ml aliquots of a solution of thymidine-2-14C  (specific 
activity 53.8 Izc/m~, New England Nuclear Corp., Boston, Mass.) diluted to a concentration 
of 1/~c/ml in MEM-S medium, were added to each tube. The cellswereharvested by centrifuga- 
tion at 580 RCF for 15 min, and washed twice in normal saline. The supernatant was discarded 
and the tubes containing the sedimented cells were put in an ice water bath. 5 ml of ice cold 
5% trichloroacetic acid  (TCA) were added to each tube. The tubes were centrifuged at 4°C 
at 1250 RCF for 20 min, and the sediments were washed twice in 5 ml aliquots of 5% ice cold 
TCA and twice in 5 ml aliquots of ice cold methanol. The washed precipitates were left to dry 
overnight at room temperature. 
The dry precipitates were suspended in I ml aliquots of hydroxide of hyamine 10-x (Packard 
Instrument Co., Inc., Downers Grove, Ill.)  and heated at 56°C  for ~  hr. The precipitates, 
resuspended in hyamine, were transferred into scintillation vials containing 5 ml of Liqnifluor 
(New England Nuclear Corp., Boston, Mass.) in toluene. The tubes which had contained the 
precipitates were rinsed twice with 2.5 ml aliquots of Liquifluor and the washings were added 
to the scintillation vials. Radioactivity in the resulting suspension was assayed in a Packard 
scintillation spectrometer and expressed in counts per minute. 
Lymphocyte Donors.--The majority of the experiments were carried out with 400 ml aliquots 
of blood, which were obtained from professional blood donors at a commercial blood bank. 21 
different donors were used in these experiments. In experiments with a single dose of heated 
and unheated streptolysin S preparations, we used 30 ml aliquots of blood obtained from 7 
healthy volunteers and from 17 ambulatory or hospitalized patients with inactive or active 
rheumatic fever, rheumatoid arthritis, or scleroderma. 
Streptolysin S Inhlbilors.--Vegetable  lecithin was purchased from Nutritional Biochemical 
Corp., Cleveland, Ohio; egg L-alpha-lecithin from General Biochemicals, Chagrin Falls, Ohio; 
L-alpha-cephalin from Calbiochem, Los Angeles, Calif.; and trypan blue from Baltimore Bio- 
logical Laboratory, Baltimore, Md. 
Enzymes.--Chymotrypsin  and  trypsin  were  purchased  from  Worthington  Biochemical 
Corporation, Freehold, N.J.; and papain, a suspension of a twice crystallized preparation, was 
purchased from Nutritional Biochemical Corp. 
Chroma2ography.--This was carried out on DEAE-Sephadex A-25  (purchased from Phar- 
macia Fine Chemicals, Piscataway, N.J.)  according to standard methods in jacketed, refrig- 
erated columns at 4°C. Aliquots of 1 to 4 ml were collected from the columns by means of an 
automatic refrigerated fraction collector. Estimates of protein and nucleic acid were made by 
determining the optical density at 280 and 260 mk~ respectively in a Beckman DU spectro- 
Valentine, F.,  and S. H. Lawrence. Manuscript in preparation. A.  TARANTA,  G.  CUPPARI~ AND  F.  QUAGLIATA  609 
photometer. Hemolytic activity was determined in each fraction, while transforming activity 
was  determined in pools of two or three consecutive fractions. 
RESULTS 
Transforming Activity of Streptolysin  S  Preparations.--Streptolysin  S prep- 
arations regularly induced high percentages  of transformation when added to 
cultures of human peripheral  blood lymphocytes from apparently healthy sub- 
jeers. Lymphocytes  obtained from the peripheral  blood of 21 professional blood 
donors were tested. The percentages  of transformation obtained with 50 HUs0 
of  streptolysin  S  preparation  ranged  from  38  to  91  with  an  average  of 
65.8 (standard deviation 16.5). These results are in essential agreement with the 
previous  report  (1). By comparison,  the percentage  of  transformation with 
PHA ranged from 60 to 100 %, with an average of 94.2 (standard deviation 8.6), 
and the per cent transformation obtained in the negative controls, without addi- 
tives, ranged from 0 to 6.5 %, with an average of 1.1 (standard deviation 1.6). 
To test the specificity of the transforming activity of streptolysin S prepara- 
tions, uninoculated Todd-Hewitt broth and "suspension medium" were added 
in 0.001 to 0.1 ml amounts to replicate lymphocyte  cultures. The transformation 
obtained did not exceed that found in the negative controls (without any addi- 
tives). 
As additional controls,  one strain each of Streptococcus ~iriclans (alpha strep- 
tococcus),  Stapkylococcus  aureus,  and  Diplococcus  pneumoniae  type  I  was 
grown in Todd-Hewitt broth.  The bacteria were collected, washed, and incu- 
bated exactly as for the production of streptolysin S by Group A beta hemolytic 
streptococci of the C203S strain. No transformation  higher than that observed in 
the negative controls was obtained with 0.001 to 0.1 ml of any of these prepara- 
tions.  These results indicate that the transforming activity of streptolysin S 
preparations is due neither to constituents of the media used for their prepara- 
tion, nor to nonspecific products of bacterial metabolism shared with these other 
Gram-positive  organisms  and obtainable in the experimental  conditions  de- 
scribed. 
Heat Inactivation of Streptolysin S Preparations.--In general accordance with 
previous reports on the marked heat lability of streptolysin S preparations (11), 
heating at 56°C for 45 rain reduced  the hemolytic activity of a 500 I-IU60/ml 
streptolysin S preparation to amounts undetectable by the standard method of 
hemolysin titration (12). One such heat-inactivated preparation was tested in 
five-fold dilutions for its ability to induce lymphocyte transformation. Cor- 
responding amounts of a nonheated aliquot of the same batch of streptolysin S 
preparation were tested concurrently. Two S-shaped dose-response curves were 
obtained (Fig. 1). They indicated that the streptolysin S preparation heated at 
56°C  for 45  rain was  still  capable  of inducing lymphocyte transformation, 
though in percentages lower than those obtained with the unheated preparation, 610  TRANS]~ORMING ACTIVITY OF STREPTOLYSIN S PREPARATIONS 
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the difference ranging from 1% to 52 % depending on the amount  of preparations 
used. The curves also indicate that similar percentages of transformation could 
be obtained with amounts of heated preparation 5-20 times greater than of un- 
heated preparation, depending on the percentage of transformation chosen for 
the comparison. 
Since it was considered critical to exclude the persistence after heating of even A. TARANTA,  G. CUPPARI,  AND  F. QUAGLIATA  611 
minute amounts of streptolysin S hemolytic activity,  lower than could be de- 
tected by the standard method of hemolysin titration, in later experiments a 
more sensitive test was adopted, with a hypotonic diluent and a lower concen- 
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tration of red cells. By the use of this "sensitized" test, small amounts of hemo- 
lytic activity were indeed detected in streptolysin S preparations with a pre- 
heating titer of 500 HU~0/ml, after heating for 45 min at 56°C. Therefore the 
preceding experiments were repeated with streptolysin  S preparations heated 
at 56°C for 2 hr, by which time the hemolytic activity had become undetectable 612  TRANSFORMING  ACTIVITY OF STREPTOLYSIN S PREPARATIONS 
by either the standard or the sensitized test. The results were essentially similar 
to those just described. 
One of the important features of the transforming activity of streptolysin S 
preparations that has been reported is that the lymphocytes of some patients, 
notably those with early active rheumatic fever, fail to transform (1).  It was 
reasoned that, if the heat-inactivated and the native streptolysin S preparations 
shared  the  same  transforming factor,  the  heat-inactivated preparation  also 
should have the characteristic of inducing less lymphocyte transformation in 
some patients, notably those with active rheumatic fever. Therefore a series of 
normal volunteers, patients with previous rheumatic fever (inactive rheumatic 
fever)  and patients with active rheumatic or connective tissue diseases were 
tested with aliquots of streptolysin S preparation containing 50 HUs0 and with 
the same amount of the same preparation heated for 2 hr at 56°C, and therefore 
devoid of any detectable hemolytic activity. The results, summarized in Fig. 2, 
indicate a significant overall correlation between the per cent transformations 
obtained with the heated and those obtained with the unheated preparation 
(r --  0.90; P  <  0.001).  The percentage of transformation was generally lower 
with the heated than with the unheated preparation, both in the normal sub- 
jects and in the patients. A detailed analysis of the clinical correlation of these 
tests in a larger patient population will be presented separately,  a 
Experiments with Streptolysin S Inhibitors.--Vegetable lecithin, egg L-alpha- 
lecithin, L-alpha-cephalin, and trypan blue were tested in preliminary experi- 
ments to find the minimum dose which would inhibit completely the hemolytic 
activity of a 500 HUs0/ml streptolysin S preparation when incubated with it for 
30 rain at 37°C. Trypan blue was found to be the most potent inhibitor on a 
weight basis under the conditions used, followed by vegetable lecithin, giving 
complete inhibition in concentrations of 3/~g and 5 mg/ml respectively. At 
these concentrations, no hemolytic activity was detected either with the stand- 
ard or the sensitized method of assay. Each of these two inhibitors was therefore 
used to abolish the hemolytic activity of a 500 HUs0/mi solution of streptolysin 
S preparation. The transforming activity of such treated preparations, tested in 
0.1 ml amounts remained essentially unchanged, as compared to the untreated 
preparation. 
To obtain more quantitative information on the relative transforming activi- 
ties of streptolysin S preparations inhibited in their hemolytic activity, a further 
experiment was done in which fivefold dilutions of streptolysin S preparation 
inactivated by trypan blue were compared with equal amounts of the same 
batch of streptolysin S preparation incubated at 37°C for 30 rain without trypan 
blue. The results, summarized in Fig. 3, indicate no loss of transforming activity 
of the trypan blue inactivated streptolysin S preparation over the range of con- 
3 Cuppari, G., F. Quagliata, A. Ieri, and A. Taranta. Manuscript in preparation. A.  TARANTA,  O.  CUPPARI,  AND  F.  QUAGLIATA  613 
centrations used. On the contrary, the trypan blue treated preparation resulted 
in slightly higher percentages of transformation, although the control cultures 
with trypan blue alone had no lymphocyte  transformation higher than the nega- 
tive controls (without additives). 
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FIG. 3. Per cent lymphocyte transformation obtained with various amounts of streptolysin 
S preparation and of the same preparation treated with trypan blue. Both preparations were 
preincubated at 37oC for 30 ruin in solutions initially containing 500 HU~0/ml. Trypan blue 
was used in a concentration of 3/~g/ml. 
Experiments with Enzymes.--Trypsin, chymotrypsin, and papain (the latter 
in 0.1% cysteine) were tested in preliminary experiments for their ability to 
reduce or eliminate the hemolytic activity of a 500 HU~0/ml solution of strep- 
tolysin S preparation in phosphate-buffered saline incubated at 37°C for 30 min. 614  TRANSFORMING  ACTIVITY  OF  STREPTOLYSIN  S PREPARATIONS 
In  general  agreement  with  previous  findings  (12),  chymotrypsin  and,  to 
a  slightly lesser extent, papain decreased drastically the hemolytic activity of 
streptolysin S preparations, while trypsin decreased it only slightly. Therefore 
chymotrypsin was chosen to inactivate streptolysin S; in addition, trypsin was 
used to determine whether a protein or a polypeptide different from streptolysin 
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FIG. 4. Per cent lymphocyte transformation obtained with various amounts of streptolysin 
S preparation and of the same preparation treated with chymotrypsin. Both preparations 
were preincubated at 37°C for 30 rain in solutions initially containing 500 HUso/ml. Chymo- 
trypsin was used in a concentration of 5 mg/ml. 
S and sensitive to trypsin might be responsible for the lymphocyte transforma- 
tion. 
The transforming activity of 500 HUs0/ml solutions of streptolysin S prepara- 
tion preincubated with 5 mg/ml of trypsin or of chymotrypsin and tested in 0.1 
ml amounts was unchanged or increased as compared to control preparations 
incubated without enzymes, although the hemolytic activity of the  chymo- 
trypsin-treated preparation  was undetectable by either  the  standard  or  the 
sensitized method of assay. 
To obtain more definitive information on the relative transforming activity of A.  TARANTA~  G.  CUPPARI~  AND  F.  QUAGLIATA 
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streptolysin S preparations  which had lost hemolytic activity upon digestion 
with  chyrnotrypsin,  two further  experiments  were  done,  with  two different 
lymphocyte donors,  but otherwise similar.  Serial  dilutions of a chymotrypsin- 
treated streptolysin S preparation  were tested for their transforming  activity 
and compared with equal amounts of the same batch of streptolysin S prepara- 
tion incubated for 30 min at 37°C, but without chymotrypsin. One of these ex- 
periments (Fig.  4) fielded somewhat higher transformations with the chymo- 
trypsin-treated  preparation.  The  other experiment fielded essentially similar 
results with either preparation.  Therefore, treatment with chymotrypsin does 
not decrease the transforming activity of streptolysin S preparations; whether a 
slight increase may result remains to he determined. 
Chromatographic  Fractionation  of  Streptolysin  S  Preparations  on  DEAE- 
Sephadex Columns.--Five fractionation experiments were carried out with small 
variations in technique, each yielding essentially similar results. Fig. 5 illustrates 
the results of a typical experiment, obtained with 1.7 ml of undialyzed strep- 
tolysin S preparation applied to a 0.9 ×  15 cm column of DEAE-Sephadex A-25. 
Starting buffer was the suspension medium minus RNA core and maltose. A 
gradient  of continuously increasing  concentrations  of sodium chloride  in the 
same buffer was then applied.  The gradient was obtained by connecting two 
cylindrical  and equal reservoirs,  A and B, with small bore tubing. Reservoir A 
was filled with the starting buffer; reservoir B was filled with the starting buffer 
saturated with sodium chloride. The buffer in reservoir A was kept in continuous 
agitation by a magnetic stirrer and was fed directly to the column. 
Three optical density peaks were obtained, two with the starting buffer and 
one with  the salt gradient.  Hemolytic activity was associated with  the  last 
optical  density peak  only. Transforming  activity was recovered only in  the 
fractions immediately preceding and overlapping the first optical density peak, 
whether  the  transformation  was  measured  morphologically  (per  cent  trans- 
formation)  or by incorporation of 14C thymidine (counts per minute). Neither 
activity was contaminated  with  the  other.  The hemolytic activity recovered 
in the eluates had the characteristic sensitivities  of streptolysin S: tested in 500 
HUs0/ml solution it was completely inhibited by heating at  56°C  for  2  hr,  or 
by incubation with 3 gg/ml of trypan  blue  or  5  mg/ml  of  chymotrypsin  at 
37°C for  30 rain.  The appearance of the cells transformed  by the chromato- 
graphic fractions could not be distinguished  from  that  of  cells transformed 
by unfractionated streptolysin S preparations. 
Similar experiments with dialyzed and lyophilized streptolysin S preparations 
resulted in similar  separation of the two activities. With the dialyzed prepara- 
tions,  the first two optical density peaks were markedly reduced while the third 
was unchanged. 
The possibility was considered  that  the  transforming  activity of the early 
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rather than in the streptolysin S preparation. To test this possibility,  "sham 
eluates" were obtained from a similarly prepared column that had been charged 
with 1.7 ml of complete suspension medium (including RNA core and maltose) 
rather than of streptolysin S preparation. Elution was carried out as for the 
streptolysin S fractionation experiments. These sham eluates proved to have no 
transforming activity. 
The possibility was also considered that the lack of transforming activity in 
the hemolytic peak might be due to an inhibiting effect on transformation of the 
sodium chloride solution or of any substance that the sodium chloride solution 
might elute from the DEAE-Sephadex column. Therefore sham eluates obtained 
at the zone in the chromatogram of the suspension medium which corresponded 
to the hemolytic peak of the chromatogram of the streptolysin S preparation 
(tubes 55-57)  were tested for their ability to inhibit transformation. Stimulus 
for transformation was provided hy a pool of the early fractions (tubes 4-6), 
containing transforming activity. No inhibitory activity was found. 
Finally, the hypothesis was considered that streptolysin S, although incap- 
able of inducing transformation by itself, might be capable of enhancing trans- 
formation of lymphocytes stimulated by the transforming factor. Therefore, 
aliquots containing 50 HUs0 of the fraction of streptolysin S preparation re- 
covered at the summit of the hemolytic peak were added to a series of dilutions 
of a pool of early fractions, endowed with transforming activity. No stimulatory 
activity of streptolysin S was detected. 
DISCUSSION 
Many antigenic substances stimulate blastogenesis  and mitotic activity in 
cultures of peripheral blood lymphocytes (reviewed in reference 22). The trans- 
formation thus obtained is limited to lymphocytes from previously sensitized 
donors. On the other hand, PHA (reviewed in reference 4), pokeweed extract 
(23, 24), staphylococcal filtrate (25), and antilymphocyte serum (26) ("non- 
specific mitogens") are capable of inducing transformation in the lymphocytes 
of all normal subjects, and the per cent transformation usually exceeds that 
obtainable with specific antigens. Streptolysin S has been reported to be another 
nonspecific mitogen (1). 
The present experiments confirm the observation that streptolysin S prepara- 
tions induce transformation in the lymphocytes of normal subjects and that the 
per cent transformation is higher than that usually observed with antigens, 
though lower than that obtainable with PHA. They also show that the trans- 
formation obtained is indeed due to a product of beta-hemolytic streptococci, 
since the uninoculated media used for the preparation of streptolysin S had no 
transforming activity, and that this product has at least some degree of species 
specificity, since neither Streptococcus viridans nor Diplococcus pneumonlae  nor 
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factor when cultured and incubated as for the production of streptolysin S. In 
addition,  the experiments here reported indicate that  the lymphocyte trans- 
formation obtainable with streptolysin S preparations is not due to streptolysin 
S, but rather to another, nonhemolytic streptococcal product or products pres- 
ent in streptolysin S preparations  but not previously recognized.  Pending its 
further characterization,  isolation,  and possible identification with one or more 
previously known streptococcal products, it may be referred to as streptococcal 
mitogen in analogy with related nomenclature ("nonspecitic mitogens," "poke- 
weed mitogen"). 
The possibility that the transforming activity of streptolysin S preparations 
might not be due to streptolysin S was first suggested by the observation that 
the C203U strain, a Group A streptococcus mutant derived from a streptolysin 
S producing strain (C203S)  but itself unable to produce streptolysin S, had re- 
tained the capacity to produce a lymphocyte mitogen when cultured and incu- 
bated as for the production of streptolysin S (10). The resulting product (C203U 
product) was less active on a weight basis than the streptolysin S preparation 
obtained from the parent strain (C203S) but was capable of inducing,  like the 
streptolysin  S  preparation,  high  percentages  of lymphocyte transformation. 
The hypothesis that the transforming activity of streptolysin S preparations is 
not dependent on their hemolytic activity has now been supported by the ob- 
servation that the transforming activity is less heat labile than the hemolytic 
activity and that, unlike the hemolytic activity, it is totally resistant to trypan 
blue, lecithin,  and chymotrypsin. Although some of these experiments are open 
to criticism  (for instance,  lymphocytes may metabolize, absorb, or otherwise 
inactivate the inhibitors,  and thus reinstitute in culture the hemolytic activity 
of streptolysin  S)  they constitute  in  their  totality strong  evidence that  the 
hemolytic activity of streptolysin S preparations can be abolished in a number 
of ways with partial  or complete preservation of their transforming  activity. 
Moreover, preliminary  observations indicate that  streptolysin S preparations 
from some streptococcal strains of groups other than A have scanty or no trans- 
forming activity, despite a high  hemolytic activity, and that the omission  of 
RNA core from the suspension medium results in preparations with transform- 
ing activity but no hemolytic activity# Finally, clear-cut separation of the two 
activities  was  achieved  by chromatographic  fractionation  of  streptolysin  S 
preparations,  with recovery of fractions  endowed with  transforming  but not 
with hemolytic activity, and of fractions endowed with hemolytic but not with 
transforming activity. AJthough  the recovery of the hemolytic activity was in- 
complete and the recovery of the transforming activity was not quantitatively 
determined,  these results, in conjunction with those just considered,  indicate 
that  the hemolytic and transforming activities of streptolysin S preparations 
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are the attributes of two different streptococcal products, the first being strep- 
tolysin S and the latter streptococcal mitogen. 
The dissociation of these two activities may have implications and applica- 
tions of interest. Some previously described biologic activities of streptolysin S 
preparations may need to be reexamined with purified preparations of streptoly- 
sin S and of streptococcal mitogen to ascertain to which one they are due, and 
other possible biologic properties of the streptococcal mitogen will need to be 
explored.  Other nonspecific mitogens have immunosuppressant properties (27, 
28) and one of them, antilymphocyte serum, is being used to prolong the survi- 
val of organ transplants in man (29). It will be interesting to ascertain whether 
the streptococcal mitogen also may depress the immune response. If it does, the 
relation of the streptococcal rnitogen  to two apparently distinct streptococcal 
products with immunosuppressant activity (30, 31) will need to be determined. 
Another property of several lymphocyte transforming agents is the stimulation 
of interferon production (32-34), which is sought for prophylaxis and therapy of 
viral diseases (35), and the streptococcal mitogen deserves investigation in this 
respect. 
The role that the streptococcal mitogen may play in streptococcal infections 
and their sequelae remains to be elucidated. If the streptococcal mitogen does 
depress the immune response it could confer to streptococci a survival advant- 
age. Lymphocytes stimulated by the streptococcal mitogen might have a dam- 
aging  effect on autologous cells, as has been demonstrated in vitro with PHA 
(36),  and  thus mediate tissue damage in  some streptococcal sequelae. These 
possibilities  are under investigation. 
SUMMARY 
The ability of streptolysin S preparations to induce high percentages of trans- 
formation in human peripheral blood lymphocytes was confirmed in a series of 
apparently healthy donors. Transforming activity was not demonstrated in the 
two media used for streptolysin S production,  nor in control preparations in 
which a strain each of Streptococcus viridans, Staphylococcus aureus (nonhemo- 
lytic), and Diplococcus  pneumoniae was substituted for the beta hemolytic strep- 
tococcal strain used for streptolysin S production. 
The relation of the hemolytic activity to the lymphocyte transforming ac- 
tivity of streptolysin S preparations was studied by means of inactivation and 
fractionation experiments. Heating produced a loss in both activities, but more 
in the hemolytic than in the transforming activity. The transformation obtained 
with a heated preparation had a high degree of correlation with that obtained 
with the unheated preparation in a series of normal subjects and patients with 
various rheumatic  diseases,  whose lymphocytes were often less responsive to 
stimulation with streptolysin S preparations (both heated and unheated) than 
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preparations with chymotrypsin, vegetable lecithin, or try-pan blue (the latter 
in minute amounts) resulted in preparations with no detectable hemolytic ac- 
tivity but with  undiminished lymphocyte transforming  activity.  Chromato- 
graphic fractionations on DEAE-Sephadex columns yidded fractions endowed 
with transforming but not with hemolytic activity, and other fractions endowed 
with hemolytic but not with transforming activity. The recovery of the hemo- 
lytic activity was not complete and quantitation of the recovery of the trans- 
forming activity was not attempted. 
These experiments indicate that the hemolytic and transforming activities of 
streptolysin S preparations are independent of each other, and specifically that 
they are the attributes of two different streptococcal products, one of which is 
streptolysin S.  The other is a  nonhemolytic streptococcal product present in 
streptolysin S preparations but previously unrecognized. Some implications of 
these findings are discussed. 
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